Since MALT1 was targeting the NF-κB pathway to increase the malignancy of CRC, miR-365a-3p and miR-375 were selected as reported in previous studies (Sun et al., 2018; Yin et al., 2019). The gene discussed is MALT1; the disease is colorectal carcinoma.